Lexeo Therapeutics (LXEO) Shares Outstanding (2022 - 2026)

Lexeo Therapeutics' Shares Outstanding history runs 5 years deep, the most recent figure standing at $74.1 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 123.21% year-over-year to $74.1 million; the TTM figure through Mar 2026 stood at $74.1 million (up 123.21% YoY), while the FY2025 annual figure was $73.0 million, up 120.74% from the prior year.
• Shares Outstanding came in at $74.1 million for Q1 2026 at Lexeo Therapeutics, up from $73.0 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $74.1 million in Q1 2026 to a low of $1.6 million in Q3 2022.
• A 5-year average of $30.4 million and a median of $33.0 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding soared 1940.15% in 2024 and grew 0.8% in 2025, its largest moves.
• Lexeo Therapeutics' Shares Outstanding stood at $1.6 million in 2022, then soared by 1557.95% to $26.6 million in 2023, then increased by 24.11% to $33.1 million in 2024, then surged by 120.74% to $73.0 million in 2025, then increased by 1.49% to $74.1 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $74.1 million, $73.0 million, and $54.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison